Le Lézard
Classified in: Health, Science and technology
Subject: TDS

Intec Pharma to Participate in the Oppenheimer Specialty Pharma Summit



JERUSALEM, October 6, 2017 /PRNewswire/ --

Intec Pharma Ltd. (NASDAQ and TASE: NTEC) today announced that management will participate in the Oppenheimer Specialty Pharma Summit to be held October 11, 2017 at the Sofitel Hotel in New York City.

Date:  Wednesday, October 11, 2017

Venue: Sofitel New York Hotel

Format:  One-on-One Meetings with Investors

Presenter: Jeffrey A. Meckler, Chief Executive Officer of Intec Pharma

The investor presentation will be posted to the Events section of the Company's website at http://www.intecpharma.com.  

About Intec Pharma Ltd. 

Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism. The Company's product pipeline includes two product candidates in clinical trial stages: Accordion Pill Carbidopa/Levodopa, or AP-CD/LD, which is being developed for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients, and AP-CBD/THC, an Accordion Pill with the two primary cannabinoids contained in Cannabis sativa, cannabidiol (CBD) and tetrahydrocannabinol (THC), which is being developed for various indications including low back neuropathic pain and fibromyalgia.

Contacts:
Jeffrey A. Meckler
Chief Executive Officer
Intec Pharma Ltd.
+1-646-374-8050
jeffrey@intecpharma.com  

SOURCE Intec Pharma Ltd.


These press releases may also interest you

at 02:00
The ICEfxtm Cryoablation system is a compact and powerful console, offering predictable, reliable performance with seamless therapy delivery and exceptional ease of technical operation BTG plc (LSE: BTG), a global specialist healthcare company,...

at 01:00
Lonza announces the addition of two new Ibextm Solutions offerings to Lonza's 100,000 m2 (1.1 million ft2) biopark in Visp (CH). In July 2017 Ibextm Dedicate, a modular, technology-agnostic biomanufacturing concept, was launched as the first Ibextm...

at 00:00
WASHINGTON, Sept. 20, 2018 /PRNewswire-PRWeb/ -- The Tinina Q. Cade Foundation recently announced the establishment of the Dr. Stephen Greenhouse Family Building Grant, in partnership with Shady Grove Fertility (SGF). This grant, specifically...

at 00:00
SANTA CLARA, Calif., Sept. 20, 2018 /PRNewswire-PRWeb/ -- The competition, an innovation challenge intended to highlight technology-enabled tools that can help support and connect individuals affected by opioid addiction, had 97 teams enter the...

at 00:00
WILMINGTON, Del., Sept. 20, 2018 /PRNewswire-PRWeb/ -- The HIPAA Privacy and Security Summit is a joint effort of Widener University Delaware Law School and First Healthcare Compliance to provide resources and increase understanding for professionals...

19 sep 2018
FALLS CHURCH, Va., Sept. 19, 2018 /PRNewswire-PRWeb/ -- Cognosante, a leader in health information technology solutions and services for Federal and state public health agencies, today announced the appointment of Jennifer Bailey as Chief People...




News published on 6 october 2017 at 07:00 and distributed by: